Elsevier Ltd provides LaTeX templates for many of its journals. Check this journal’s author guidelines, and we can convert your manuscript into its template.
LaTeX Template Conversion →Journals listed in Web of Science and JCR receive many submissions and desk reject a large share. A section-by-section audit by a PhD reviewer in your area shows what to fix first.
Manuscript Auditing →01Impact factor
Impact factor of Neuropharmacology (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Neuropharmacology published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, applied to the open citation data of OpenAlex. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Pharmacology & Pharmacyrank 90 of 371 journals
- Neurosciencesrank 85 of 321 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of Neuropharmacology
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Neuropharmacology is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
Article processing charge listed at about US$4,300.
02Fee waivers
APC waivers and discounts for Neuropharmacology
Neuropharmacology follows the waiver policy of its publisher, Elsevier: automatic 100% waiver for Research4Life Group A and 50% for Group B in fully open access journals, but only when every author is in an eligible country.
Authors affiliated in 82 countries qualify for a full waiver. See the countries →
Waivers apply to fully open access journals. If Neuropharmacology is a hybrid journal, you can publish without any fee through the subscription route.
Checking the waiver rules for your country…
Retractions and research integrity at Neuropharmacology
Retractions per year
Most common reasons (a retraction can have several):
Neuropharmacology has 5 retracted papers in the Retraction Watch database, the latest in May 2024. A retraction count is not a verdict on a journal: large journals publish more and journals that investigate actively retract more. The trend and the reasons tell you more than the number.
Who funds research published in Neuropharmacology
Funders named most often
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
Submitting to Neuropharmacology? See your rejection risk first.
Seven questions our reviewers ask in every audit, plus your abstract and the fit with this journal. Free, no sign-up, about 2 minutes.
03Indexing
Indexing of Neuropharmacology
- ISSN
- 0028-3908
- eISSN
- 1873-7064
- Publisher
- Elsevier Ltd all its journals →
- Country
- England
- Language
- English
- Scopus source type
- Journal
- Web of Science categories
- Neurosciences, Pharmacology & Pharmacy
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor and quartile on this page are calculated from OpenAlex open data (see how the impact factor works).
Each link opens the official record for this journal, searched by its ISSN where we have one.
04How to submit
How to submit to Neuropharmacology
- Read the guide for authors. It sets the article types, word limit, reference style and file format that Neuropharmacology accepts. You find it on the official website of the journal, usually under "For authors" or "Submit".
- Use the journal's template. Elsevier Ltd offers Word and LaTeX templates for many of its journals. If your manuscript is in Word and the journal wants LaTeX, our LaTeX Template Conversion moves it into the template.
- Check the fit. Compare your title and abstract with the papers it has published; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Check the fee. Neuropharmacology is not a fully open access journal, so authors usually pay nothing unless they choose open access for their article or the journal charges page or colour fees. The guide for authors states the current charges.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
05What it publishes
What Neuropharmacology publishes: real papers
06Published papers
Papers published in Neuropharmacology
Papers from the publication records ScholarsColab tracks, with their year and citations. Author names are not shown.
- New Ischemic Stroke Therapy Targeting NVU Components20260 citations
07Reviewer comments
Reviewer comments and rejection reasons for Neuropharmacology
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Neuropharmacology, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 secondsPreparing to submit here? Make sure reviewers don't stop at the issues they raise most often. A PhD reviewer in your area can audit your manuscript section by section, and we can convert it into the journal's LaTeX template.
08Similar journals
Journals similar to Neuropharmacology
Journals that publish the closest work to the papers above, from the indexing lists:
- PLoS ONESCIEScopusJCR 202415 similar papers
- Frontiers in NeurologySCIEScopusJCR 202432 similar papers
- PeerJSCIEScopusJCR 202414 similar papers
- Frontiers in ImmunologySCIEScopusJCR 20249 similar papers
- Frontiers in Human NeuroscienceSCIEScopusJCR 20247 similar papers
- Frontiers in Public HealthSCIESSCIScopusJCR 20245 similar papers
09Same subject
Pharmacology & Pharmacy journals with a similar impact factor*
The journals next to Neuropharmacology when the 354 journals of Pharmacology & Pharmacy in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 86 | International Journal of Antimicrobial Agents | 4.21 | SCIE | Subscription |
| 87 | Clinical Pharmacology & Therapeutics | 4.21 | SCIE | Subscription |
| 88 | International Journal for Parasitology Drugs and Drug Resistance | 4.21 | SCIE | Fully open access |
| 89 | Chinese Journal of Natural Medicines | 4.19 | SCIE | Subscription |
| 91 | Current Pharmaceutical Analysis | 4.14 | SCIE | Subscription |
| 92 | Journal of Microencapsulation | 4.09 | SCIE | Subscription |
| 93 | American Journal of Cardiovascular Drugs | 4.08 | SCIE | Subscription |
| 94 | Expert Review of Anti-infective Therapy | 4.08 | SCIE | Subscription |
*Impact factor calculated from OpenAlex open data (2-year citedness), not the official Clarivate value.
10Journal Finder
Find the right journal for your paper
Is Neuropharmacology right for your paper? Compare journals
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 156,503 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated from OpenAlex open data, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time comes from the dates publishers deposit in Crossref (not every publisher deposits them). Always check a journal’s scope and current indexing before submitting.
11Questions
Frequently asked questions
What is the impact factor of Neuropharmacology?
Based on OpenAlex citation data (October 2026), the 2-year impact factor of Neuropharmacology is 4.16: papers it published in the two previous years were cited 4.16 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of Neuropharmacology?
The h-index of Neuropharmacology is 245 (OpenAlex, October 2026): 245 of its papers have each been cited at least 245 times. Its i10-index is 11,305.
What is the APC of Neuropharmacology?
OpenAlex lists an article processing charge (APC) of about US$4,300 for Neuropharmacology (data from October 2026). APCs change and can differ by article type, country or discounts, so confirm the current charge on the journal’s website before submitting.
What is the quartile of Neuropharmacology?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Neuropharmacology is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is Neuropharmacology indexed in Scopus?
Yes. Neuropharmacology appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Neuropharmacology an SCIE journal?
Yes. Neuropharmacology is listed in the Science Citation Index Expanded (SCIE), according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Neuropharmacology in Journal Citation Reports (JCR)?
Yes. Neuropharmacology is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
How many papers published in Neuropharmacology does ScholarsColab track?
We track 1 paper published in Neuropharmacology in 2026, cited 0 times in total, with a median of 0 citations per paper.
Does Neuropharmacology offer an APC waiver?
Neuropharmacology follows the policy of Elsevier: automatic 100% waiver for Research4Life Group A and 50% for Group B in fully open access journals, but only when every author is in an eligible country. Rules verified 27 October 2026; confirm on the publisher's page.
Has Neuropharmacology retracted papers?
Yes. The Retraction Watch database lists 5 retracted papers in Neuropharmacology, 4 of them in the last 10 years; the most common reasons are duplication of/in image, falsification/fabrication of data, manipulation of images. A retraction count alone is not a verdict on a journal; look at the trend and the reasons. Data updated October 2026.
Who funds research published in Neuropharmacology?
77% of 200 recent research articles in Neuropharmacology name a funder in Crossref; the funders named most often are National Natural Science Foundation of China, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism.
Want a PhD expert to choose the journal with you?
Our Journal Selection & Submission service shortlists up to 5 journals that match your manuscript, indexing requirement and target quartile, and handles the submission. If your paper was rejected before, a Manuscript Audit shows what to fix first.
Not sure yet? Check your manuscript for this journal, free · How the process works
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Journal of Cleaner Production
- International Journal of Hydrogen Energy
- Journal of Colloid and Interface Science
- Journal of Magnetism and Magnetic Materials
- Applied Surface Science
- Langmuir
- Journal of Clinical Oncology
- Environmental Science and Pollution Research
- Remote Sensing
- Frontiers in Psychology
- Angewandte Chemie - International Edition
- Journal of Materials Science
- Molecules
- Journal of Organometallic Chemistry
Browse all journals: indexing, impact factor and reviewer comments →